First Time Loading...

Chongqing Zhifei Biological Products Co Ltd
SZSE:300122

Watchlist Manager
Chongqing Zhifei Biological Products Co Ltd Logo
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Watchlist
Price: 35.1 CNY -1.68% Market Closed
Updated: May 4, 2024

Chongqing Zhifei Biological Products Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chongqing Zhifei Biological Products Co Ltd
Operating Income Peer Comparison

Comparables:
6160
1801
603392
S
002252
300896

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
¥9.9B
CAGR 3-Years
38%
CAGR 5-Years
46%
CAGR 10-Years
47%
Beigene Ltd
HKEX:6160
Operating Income
-¥12B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
-¥1.1B
CAGR 3-Years
-36%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
¥1.4B
CAGR 3-Years
22%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Operating Income
¥2B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
22%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Income
¥1.4B
CAGR 3-Years
59%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Chongqing Zhifei Biological Products Co Ltd's Operating Income?
Operating Income
9.9B CNY

Based on the financial report for Sep 30, 2023, Chongqing Zhifei Biological Products Co Ltd's Operating Income amounts to 9.9B CNY.

What is Chongqing Zhifei Biological Products Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
47%

Over the last year, the Operating Income growth was 14%. The average annual Operating Income growth rates for Chongqing Zhifei Biological Products Co Ltd have been 38% over the past three years , 46% over the past five years , and 47% over the past ten years .